AXA Framlington Biotech Z Inc
SpecialistPricing frequency
Daily
Dealing cut off time
10:45
Type
Unit Trust
Yield
-
NAV
174.40p
Ongoing charge
0.8%
Latest actual NAV date
24-04-2024
ISIN
GB00BRJZVL27
UCITS
Yes
This fund can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Regular investment
Before investing please read:
Growth of 10k
Asset allocation
Top 10 holdings
Holdings 31/03/2024 | % of assets |
---|---|
Regeneron Pharmaceuticals Inc | 8.93 |
Vertex Pharmaceuticals Inc | 6.97 |
Amgen Inc | 6.01 |
Biogen Inc | 4.73 |
Moderna Inc | 3.25 |
Novo Nordisk A/S Class B | 3.21 |
Neurocrine Biosciences Inc | 2.83 |
Gilead Sciences Inc | 2.77 |
argenx SE ADR | 2.58 |
Eli Lilly and Co | 2.45 |
Investment objective
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed companies, principally in the biotechnology, genomic and medical research industry, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world, albeit the Fund tends to be biased towards the US as this is where the majority of biotechnology companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.
Morningstar ratingTM
Morningstar sustainability ratingTM
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.